Brookfield is seeking an A$750m loan that converts to $525 million to fund a payout to investors in its Australian non‑bank lender La Trobe Financial and to refinance existing debt. The facility is a covenant‑lite term loan B with an interest margin of 475 basis points over the benchmark Bank Bill Swap Yield.

A dividend recap loads fresh debt onto a portfolio firm to finance a payout, a tactic buyouts deploy when sales or IPOs stall. Brookfield joins peers such as Warburg Pincus and CVC in similar APAC deals. Earlier this year it sold a minority stake in La Trobe to Abu Dhabi’s Axight Capital, valuing the lender at $2.1 bn after ASIC‑imposed bans triggered outflows.

Brookfield faces pressure beyond La Trobe, having booked a $1.4 bn loss on Healthscope, now in administration. By loading debt, the sponsor can keep cash flowing to limited partners despite weak exit markets, yet the move adds leverage to a lender still recovering from regulatory curbs. The loan secures immediate distribution but raises the risk profile of La Trobe's balance sheet.